OBJECTIVE: Cytokines released by epicardial fat are implicated in the pathogenesis of atherosclerosis. HIV infection and antiretroviral therapy have been associated with changes in body fat distribution and coronary artery disease. We sought to determine whether HIV infection is associated with greater epicardial fat and whether epicardial fat is associated with subclinical coronary atherosclerosis. DESIGN: We studied 579 HIV-infected and 353 HIV-uninfected men aged 40-70 years with noncontrast computed tomography to measure epicardial adipose tissue (EAT) volume and coronary artery calcium (CAC). Total plaque score (TPS) and plaque subtypes (noncalcified, calcified, and mixed) were measured by coronary computed tomography angiography in 706 men. METHODS: We evaluated the association between EAT and HIV serostatus, and the association of EAT with subclinical atherosclerosis, adjusting for age, race, and serostatus and with additional cardiovascular risk factors and tested for modifying effects of HIV serostatus. RESULTS: HIV-infected men had greater EAT than HIV-uninfected men (P=0.001). EAT was positively associated with duration of antiretroviral therapy (P=0.02), specifically azidothymidine (P<0.05). EAT was associated with presence of any coronary artery plaque (P=0.006) and noncalcified plaque (P=0.001), adjusting for age, race, serostatus, and cardiovascular risk factors. Among men with CAC, EAT was associated with CAC extent (P=0.006). HIV serostatus did not modify associations between EAT and either CAC extent or presence of plaque. CONCLUSION: Greater epicardial fat volume in HIV-infected men and its association with coronary plaque and antiretroviral therapy duration suggest potential mechanisms that might lead to increased risk for cardiovascular disease in HIV.
OBJECTIVE: Cytokines released by epicardial fat are implicated in the pathogenesis of atherosclerosis. HIV infection and antiretroviral therapy have been associated with changes in body fat distribution and coronary artery disease. We sought to determine whether HIV infection is associated with greater epicardial fat and whether epicardial fat is associated with subclinical coronary atherosclerosis. DESIGN: We studied 579 HIV-infected and 353 HIV-uninfectedmen aged 40-70 years with noncontrast computed tomography to measure epicardial adipose tissue (EAT) volume and coronary artery calcium (CAC). Total plaque score (TPS) and plaque subtypes (noncalcified, calcified, and mixed) were measured by coronary computed tomography angiography in 706 men. METHODS: We evaluated the association between EAT and HIV serostatus, and the association of EAT with subclinical atherosclerosis, adjusting for age, race, and serostatus and with additional cardiovascular risk factors and tested for modifying effects of HIV serostatus. RESULTS:HIV-infectedmen had greater EAT than HIV-uninfectedmen (P=0.001). EAT was positively associated with duration of antiretroviral therapy (P=0.02), specifically azidothymidine (P<0.05). EAT was associated with presence of any coronary artery plaque (P=0.006) and noncalcified plaque (P=0.001), adjusting for age, race, serostatus, and cardiovascular risk factors. Among men with CAC, EAT was associated with CAC extent (P=0.006). HIV serostatus did not modify associations between EAT and either CAC extent or presence of plaque. CONCLUSION: Greater epicardial fat volume in HIV-infectedmen and its association with coronary plaque and antiretroviral therapy duration suggest potential mechanisms that might lead to increased risk for cardiovascular disease in HIV.
Authors: Janet Lo; Suhny Abbara; Leon Shturman; Anand Soni; Jeffrey Wei; Jose A Rocha-Filho; Khurram Nasir; Steven K Grinspoon Journal: AIDS Date: 2010-01-16 Impact factor: 4.177
Authors: Janet Lo; Suhny Abbara; Jose A Rocha-Filho; Leon Shturman; Jeffrey Wei; Steven K Grinspoon Journal: AIDS Date: 2010-08-24 Impact factor: 4.177
Authors: Naser Ahmadi; Vahid Nabavi; Fereshteh Hajsadeghi; Ferdinand Flores; William J French; Song S Mao; David Shavelle; Ramin Ebrahimi; Matthew Budoff Journal: Am J Cardiol Date: 2011-01 Impact factor: 2.778
Authors: Sandeep R Pagali; Paul Madaj; Mohit Gupta; Subu Nair; Yasmin S Hamirani; James K Min; Faye Lin; Matthew J Budoff Journal: J Cardiovasc Comput Tomogr Date: 2010-06-08
Authors: Netanya S Utay; Douglas W Kitch; Eunice Yeh; Carl J Fichtenbaum; Michael M Lederman; Jacob D Estes; Claire Deleage; Clara Magyar; Scott D Nelson; Karen L Klingman; Barbara Bastow; Amneris E Luque; Grace A McComsey; Daniel C Douek; Judith S Currier; Jordan E Lake Journal: J Infect Dis Date: 2018-05-05 Impact factor: 5.226
Authors: Jonathan Buggey; Leo Yun; Chung-Lieh Hung; Cissy Kityo; Grace Mirembe; Geoffrey Erem; Tiffany Truong; Isaac Ssinabulya; W H Wilson Tang; Brian D Hoit; Grace A McComsey; Chris T Longenecker Journal: Heart Date: 2019-09-19 Impact factor: 5.994
Authors: Chris T Longenecker; Seunghee Margevicius; Yiying Liu; Mark D Schluchter; Chun-Ho Yun; Hiram G Bezerra; Grace A McComsey Journal: Am J Cardiol Date: 2017-07-24 Impact factor: 2.778
Authors: Diana K Thiara; Chia Ying Liu; Fabio Raman; Sabrina Mangat; Julia B Purdy; Horacio A Duarte; Nancyanne Schmidt; Jamie Hur; Christopher T Sibley; David A Bluemke; Colleen Hadigan Journal: J Infect Dis Date: 2015-05-11 Impact factor: 5.226
Authors: Suman Srinivasa; Michael T Lu; Kathleen V Fitch; Travis R Hallett; Timothy K O'Malley; Lauren A Stone; Amanda Martin; Alexandra J Coromilas; Tricia H Burdo; Virginia A Triant; Janet Lo; Sara E Looby; Tomas G Neilan; Markella V Zanni Journal: Antivir Ther Date: 2018
Authors: Micaela Iantorno; Sahar Soleimanifard; Michael Schär; Todd T Brown; Gabriele Bonanno; Patricia Barditch-Crovo; Lena Mathews; Shenghan Lai; Gary Gerstenblith; Robert G Weiss; Allison G Hays Journal: Atherosclerosis Date: 2018-08-17 Impact factor: 5.162
Authors: Louisa C Howard; Chia-Ying Liu; Julia B Purdy; Peter Walter; David A Bluemke; Colleen Hadigan Journal: J Clin Endocrinol Metab Date: 2015-11-10 Impact factor: 5.958